NCT04528511Recruiting
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction: the BENEFIT-AMI Multicenter Prospective Registry
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 774 (estimated)
- First submitted
- 23 Aug 2020
- Start date
- 1 Oct 2020
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Shanghai 10th People's Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT04528511
What you commit to
- Study type: Observational
- Planned participants: 774
- From 1 Oct 2020 to the primary completion date, 31 Dec 2027
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing emergent coronary artery bypass surgery;
Other illness
- Patients with a medical history of pre-existing AF;
- Patients with a medical history of rheumatic valvular disease;
- Patients with a medical history of sick sinus syndrome;
- Patients who suffer malignant tumors with an expected lifetime less than 1 year ;
- Patients who refuse to receive CEM during hospitalization and the data of heart rhythm cannot be retrieved;
Other
- Patients who refuse to receive percutaneous coronary intervention (PCI) or have contraindications for PCI;
- Patients who have died during the index hospitalization.
Who the study is looking for
- Adult patients (\>18 years old);
- Patient with AMI (including STEMI and NSTEMI) who developed NOAF during the index hospitalization;
- Patients must have received in-hospital CEM for at least 5 days;
- Patients must give informed consent.
Age in the registry: 18 years to - · Sex: All
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaifeng Central Hospital Coordinator of this site? Confirm its status | Kaifeng | China | Recruiting |
| Luoyang Central Hospital Coordinator of this site? Confirm its status | Luoyang | China | Recruiting |
| Department of Cardiology, Shanghai Tenth People's Hospital Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
| Shanghai Seventh People's Hospital Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
| The First Affiliated Hospital of Zhengzhou University Coordinator of this site? Confirm its status | Zhengzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.